This

is a cohort study of non diabetic patients with chronic kidney disease which shows that fibroblast growth factor 23 (FGF23) is an independent predictor of progression of chronic kidney disease. FGF23 is a phosphaturic hormone, triggered by increased phosphate levels. In addition to causing phosphaturia it may inhibit the 1-alpha-hydroxylase, decreasing the activation of vitamin D and increasing PTH levels.

to the article

To quote this article in bibliography using Chicago style :

Fliser, Danilo, Barbara Kollerits, Ulrich Neyer, Donna P. Ankerst, Karl Lhotta, Arno Lingenhel, Eberhard Ritz, Florian Kronenberg. “Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study." Journal of the American Society of Nephrology 18, no. 9 (2007): 2600-2608. https://doi.org/10.1681/ASN.2006080936

Join us in the social media!

Click here to subscribe to our Telegram Channel!

Click here to join to our Telegram Group for discussions